About Cure51
Innovative French TechBio company dedicated to finding novel Cancer treatments based on exceptional Cancer survivors' biology.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
cure51.com
Domain Registered Date
Sep 27, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $16,000,000 · Seed
startupintros.com
- Milestone
Website domain registered
cure51.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Cure51.
Funding History
Seed
· Mar 20, 2024
$16,000,000 startupintros.com
Founders & Leadership
EL MEHDI OUZGANE
Late Founder COO
Work email & phone locked
Unlock →
NICOLAS WOLIKOW
Co-Founder CEO
Work email & phone locked
Unlock →
PALOMA CEJAS
Late Founder Head of Translational Research
Work email & phone locked
Unlock →
RÉMY NICOLLE
Late Founder Senior Advisor
Work email & phone locked
Unlock →
SIMON ISTOLAINEN
Co-Founder Chief Strategy Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026